These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11043489)

  • 1. Bismuth biokinetics and kidney histopathology after bismuth overdose in rats.
    Leussink BT; Slikkerveer A; Krauwinkel WJ; van der Voet GB; de Heer E; de Wolff FA; Bruijn JA
    Arch Toxicol; 2000 Sep; 74(7):349-55. PubMed ID: 11043489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways of proximal tubular cell death in bismuth nephrotoxicity.
    Leussink BT; Nagelkerke JF; van de Water B; Slikkerveer A; van der Voet GB; Srinivasan A; Bruijn JA; de Wolff FA; de Heer E
    Toxicol Appl Pharmacol; 2002 Apr; 180(2):100-9. PubMed ID: 11969377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bismuth overdosing-induced reversible nephropathy in rats.
    Leussink BT; Slikkerveer A; Engelbrecht MR; van der Voet GB; Nouwen EJ; de Heer E; de Broe ME; de Wolff FA; Bruijn JA
    Arch Toxicol; 2001 Feb; 74(12):745-54. PubMed ID: 11305776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicity.
    Leussink BT; Litvinov SV; de Heer E; Slikkerveer A; van der Voet GB; Bruijn JA; de Wolff FA
    Toxicol Appl Pharmacol; 2001 Aug; 175(1):54-9. PubMed ID: 11509026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate].
    Zhang L; Zhang ST; Yu ZL; Shao Y
    Zhonghua Nei Ke Za Zhi; 2005 Apr; 44(4):272-5. PubMed ID: 15924641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate.
    Işlek I; Uysal S; Gök F; Dündaröz R; Küçüködük S
    Pediatr Nephrol; 2001 Jun; 16(6):510-4. PubMed ID: 11420918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate.
    Canena J; Reis J; Pinto AS; Santos AM; Leitão J; Pinheiro T; Quina MG
    J Pharm Pharmacol; 1998 Mar; 50(3):279-83. PubMed ID: 9600719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure after overdose of colloidal bismuth subcitrate.
    Cengiz N; Uslu Y; Gök F; Anarat A
    Pediatr Nephrol; 2005 Sep; 20(9):1355-8. PubMed ID: 15947979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of bismuth from 205Bi-labelled pharmaceutical oral Bi-preparations in rats.
    Dresow B; Nielsen P; Fischer R; Wendel J; Gabbe EE; Heinrich HC
    Arch Toxicol; 1991; 65(8):646-50. PubMed ID: 1747063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine synthetase activity in rat urine as sensitive marker to detect S3 segment-specific injury of proximal tubule induced by xenobiotics.
    Trevisan A; Cristofori P; Fanelli G
    Arch Toxicol; 1999; 73(4-5):255-62. PubMed ID: 10463391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of bismuth from several bismuth compounds during in vivo perfusion of rat small intestine.
    Slikkerveer A; Helmich RB; van Der Voet GB; de Wolff FA
    J Pharm Sci; 1995 Apr; 84(4):512-5. PubMed ID: 7629747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
    Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
    Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.
    Froomes PR; Wan AT; Keech AC; McNeil JJ; McLean AJ
    Eur J Clin Pharmacol; 1989; 37(5):533-6. PubMed ID: 2598996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease.
    Dresow B; Fischer R; Gabbe EE; Wendel J; Heinrich HC
    Scand J Gastroenterol; 1992 Apr; 27(4):333-6. PubMed ID: 1589712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucus.
    Muñoz DJ; Tasman-Jones C; Pybus J
    Gut; 1992 May; 33(5):592-6. PubMed ID: 1377152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate.
    Stiel D; Murray DJ; Peters TJ
    Gut; 1985 Apr; 26(4):364-8. PubMed ID: 3979909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration.
    Piotrowski J; Bilski J; Nishikawa H; Slomiany A; Slomiany BL
    Eur J Pharmacol; 1990 Aug; 184(1):55-63. PubMed ID: 2209715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety profile of De-Nol.
    Bader JP
    Digestion; 1987; 37 Suppl 2():53-9. PubMed ID: 3622947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective effect of vitamin C against gentamicin-induced acute kidney injury in rats.
    Stojiljkovic N; Stoiljkovic M; Randjelovic P; Veljkovic S; Mihailovic D
    Exp Toxicol Pathol; 2012 Jan; 64(1-2):69-74. PubMed ID: 20619622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative absorption of bismuth in Sprague-Dawley rats following oral administration of preparations containing bismuth sucrose octasulfate, bismuth subsalicylate, and bismuth subcitrate.
    Rao N; Brown PW; Yerino P; Chang J; Hwang KK
    Biopharm Drug Dispos; 1997 Jan; 18(1):1-8. PubMed ID: 9008264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.